The gastric emptying effect is the most significant
In addition, increased fat mass and decreased muscle mass contribute to insulin resistance in these patients
This peptide works on all three receptors, giving it more metabolic benefits than single or dual agonists like semaglutide or tirzepatide
From this perspective, receptor-level signaling alone may be insufficient to ensure durable tissue-level outcomes
Both drugs share common, generally mild-to-moderate gastrointestinal side effects (nausea, vomiting, diarrhea) common to all incretin-based therapies
For us, this is a brand-new tool in our toolbox to benefit the quality of life in these patients." While GLP-1s are being seen as the hearts newest best friend, on the flip side, obesity is one of its worst enemies